The global endoscopic vessel harvesting system market size is expected to reach USD 195.1 billion by 2030, according to a new study by Grand View Research, Inc. The market is expected to expand at a CAGR of 3.5% from 2023 to 2030. The increasing prevalence of cardiovascular diseases globally, such as peripheral artery disease & coronary artery disease, and growing preference for minimally invasive harvesting attributed to its benefits over conventional methods, and the rising geriatric population. According to World Health Organization study published in May 2024, in Europe, CVDs are the leading cause of disability and premature death. Statistics indicate that CVDs account for over 42.0% of all deaths annually in Europe. That is approximately 10,000 deaths every day attributed to cardiovascular diseases.
Moreover, the growing incidents of heart disorders including atrial fibrillation, and angina pectoris, are a leading cause of morbidity and mortality globally. For instance, according to the National Library of Medicine, the prevalence of angina pectoris worldwide ranged from approximately 2% to 7% in 2024.
In addition, the increasing demand for coronary artery bypass graft (CABG) surgeries. CABG is a procedure commonly used to address coronary artery disease (CAD). With factors such as aging populations, sedentary lifestyles, and rising rates of diabetes and obesity contributing to the growing prevalence of CAD, there has been a corresponding rise in the number of CABG procedures. This uptick in CABG surgeries underscores the necessity for efficient and minimally invasive harvesting techniques like EVH.
Request a free sample copy or view report summary: Endoscopic Vessel Harvesting System Market Report
By product, disposable segment accounted for the largest revenue share in 2023. The growth is attributed to reducing the risk of cross-contamination and infection, addressing heightened awareness and regulatory requirements regarding hospital-acquired infections.
By application, coronary artery disease (CAD) segment accounted for the largest market share in 2023. The growth is owed to the rising need to diagnose and monitor patients with CAD efficiently and accurately.
In 2023, North America dominated the overall market owing to due to rising prevalence of chronic diseases, quick acceptance of technological device improvements, and rising elderly population.
Grand View Research has segmented the global endoscopic vessel harvesting system market based on product, application, and region:
Endoscopic Vessel Harvesting System Product Outlook (Revenue, USD Million, 2018 - 2030)
Disposable
Re-usable
Endoscopic Vessel Harvesting System Application Outlook (Revenue, USD Million, 2018 - 2030)
Coronary Artery Disease (CAD)
Peripheral Artery Disease (PAD)
Endoscopic Vessel Harvesting System Region Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Norway
Sweden
Denmark
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players of Endoscopic Vessel Harvesting System Market
MAQUET Holding B.V. & Co. KG
CARDIO MEDICAL GmbH
Terumo Cardiovascular Group
Med Europe S.r.l. (Elite Life Care)
LivaNova plc. (Sorin and Cyberonics)
Saphena Medical, Inc.
Getinge AB
Olympus Corporation
Saphena Medical
KARL STORZ
Medical Instruments S.p.a
"The quality of research they have done for us has been excellent..."